Back to results
US 2016/0102107 A1Published application
Pyrazolo-pyrrolidin-4-one derivatives as bet inhibitors and their use in the treatment of disease
AssigneeNovartis AG
InventorsJutta BLANK, Guido BOLD, Simona COTESTA, Vito GUAGNANO, Heinrich RUEEGER
Life of this patent
Estimating the term…
Abstract
The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof; (I) a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
Claims12
A compound of formula (I) or a pharmaceutically acceptable salt thereof,
- wherein
- A is selected from
- B is
- C is
- R1 is methyl, optionally substituted with one or two fluoro;
- R2 is selected from chloro and fluoro;
- R3 is selected from (C1-C4)alkyl and cyclopropyl;
- and R4 is selected from (C1-C4)alkyl, optionally substituted by —OH or —O—(C1-C4)alkyl;
- halo(C1-C4)alkyl substituted by —OH;
- or
- or
- R3 is
- and R4 is selected from H;
- (C1-C4)alkyl optionally substituted by —OH or —O—(C1-C4)alkyl;
- and cyclopropyl;
- R5 is H;
- R6 is selected from methyl, methoxy, —NH2 and —NH—C(O)—(C1-C4)alkyl R7 is methoxy;
- and * indicates the point of attachment to the remainder of the molecule.
15 more elements
-14. (canceled)
Dependencies are inferred from the claim text.